Atrial fibrillation is associated with increased risks of death, cardiovascular disease, and renal disease, highlighting the need for comprehensive management beyond stroke prevention.
Atrial fibrillation is associated with an increased risk of death and an increased risk of cardiovascular and renal disease. Interventions aimed at reducing outcomes beyond stroke are warranted in patients with atrial fibrillation.
Odutayo et al. (2016) studied this question.